Propylthiouracil associated antineutrophil cytoplasmic antibodies (ANCA) in patients with childhood onset graves' disease

Journal of Pediatric Endocrinology and Metabolism

Volumn 21, Issue 6, 2008, Pages 539-543

  Panamonta, Ouyporn ^a   Sumethkul, Vasant ^b   Radinahmed, Piyanuth ^b   Laopaiboon, Malinee ^a   Kirdpon, Wichitr ^c  

^a KHON KAEN UNIVERSITY   (Thailand)

^b MAHIDOL UNIVERSITY   (Thailand)

^c KHON KAEN UNIVERSITY   (Thailand)

Author keywords

ANCA; Antineutrophil cytoplasmic antibodies; Childhod; Grave's disease; Prevalence; Prophylthiouracil

Indexed keywords

ANTIINFLAMMATORY AGENT; ANTINUCLEAR ANTIBODY; CREATININE; MYELOPEROXIDASE; NEUTROPHIL CYTOPLASMIC ANTIBODY; NITROGEN; PROPYLTHIOURACIL; RADIOACTIVE IODINE; STEROID; THIAMAZOLE; UREA;

ADOLESCENT; ADULT; ANTIBODY DETECTION; CHILD; CHILDHOOD ONSET GRAVES DISEASE; CLINICAL FEATURE; CONFERENCE PAPER; CREATININE BLOOD LEVEL; DRUG WITHDRAWAL; FEMALE; GRAVES DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; UREA NITROGEN BLOOD LEVEL; URINALYSIS; VASCULITIS;

ADOLESCENT; ADULT; AGE OF ONSET; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; ANTITHYROID AGENTS; CHILD; FEMALE; GRAVES DISEASE; HUMANS; MALE; PREVALENCE; PROPYLTHIOURACIL; VASCULITIS;

EID: 48449105008     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (26)

1. Hagen E, Daha M, Hermans J, Andrassay K, Csemok K, Lesavre P, Ludermann J, Rasmussen N, Sinico RA, Wiik A, van der Woude FJ. Diagnostic value of standardised assays for antineutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. Kidney Int 1998; 53: 743-753.
2. Dolman K, Gans R, Vervaat T, Zevenberg G, Maingay D, Nikkels R, Donker AJM, von-dem-Borne AEGK, Goldschmeding R. Vasculitis and antineutrophil cytoplasmic autoantibodies associated with propylthiouracil therapy. Lancet 1993; 342: 651-652.
3. Choi HK, Merkel PA, Walker AM, Niles JL. Drug associated ANCA-positive vasculitis: prevalence among patient with high titers of anti-MPO antibodies. Arthritis Rheum 2000; 43: 405-413.
4. Gao Y, Zhao MH, Guo XH, Xin G, Gao Y, Wang HY. The prevalence of target antigens of antithyroid drug induced antineutrophil cytoplasmic antibodies (ANCA) in Chinese patients with hyperthyroidism. Endocrinol Res 2004; 30: 205-213.
5. Gunton JE, Stiel J, Clifton-Bligh P, Wilmshurst E, McElduff A. Prevalence of positive antineutrophil cytoplasmic antibody (ANCA) in patients receiving antithyroid medication. Eur J Endocrinol 2000; 142: 587-590.
6. Sera N, Ashizawa K, Ando T, Abe Y, Ide A, Usa T, Tominaga T, Ejima E, Yokoyama N, Eguchi K. Treatment with propylthiouracil is associated with appearance of antineutrophil cytoplasmic antibodies in some patients with Graves disease. Thyroid 2000; 10: 595-599.
7. Noh JY, Asari T, Hamada N, Makino F, Ishikawa N, Abe Y, Ito K, Ito K. Frequency of appearance of myelo-peroxidase-antineutrophil cytoplasmic antibody (MPO-ANCA) and clinical manifestations. Clin Endocrinol (Oxf) 2001; 54: 651-654.
8. Sato H, Hattori M, Fujieda M, Sugihara S, Inomata H, Hoshi M, Miyamoto S. High prevalence of antineutrophil cytoplasmic antibody positivity in childhood onset Graves' disease treated with propylthiouracil. J Clin Endocrinol Metab 2000; 85: 4270-4273.
9. Fujieda M, Hattori M, Kurayama, H, Koitabashi Y, Members and Coworkers of the Japanese Society for Pediatric Nephrology. Clinical features and outcomes in children with antineutrophil cytoplasmic autoantibody-positive glomerulonephritis associated with propylthiouracil treatment. J Am Soc Nephrol 2002; 13: 437-445.
10. Winters MJ, Hurley RM, Lirenman DS. ANCA-positive glomerulonephritis and IgA nephropathy in a patient on propylthiouracil. Pediatr Nephrol 2002; 17: 257-260.
11. Poomthavorn P, Mahachoklertwattana P, Tapaneya-Olarn W, Chuansumrit A, Chunharas A. Antineutrophil cytoplasmic antibody-positive systemic vasculitis associated with propylthiouracil therapy: report of 2 children with Graves' disease. J Med Assoc Thai 2002; 85 (Suppl 4): S1295-1301.
12. Fujieda M, Nagata M, Akioka Y, Hattori M, Kawaguchi H, Ito K. Antineutrophil cytoplasmic antibody-positive crescentic glomerulonephritis associated with propylthiouracil therapy. Acta Pediatr Jpn 1998; 40: 286-289.
13. Vogt BA, Kim Y, Jennette C, Falk RJ, Burke BA, Sinaiko A. Antineutrophil cytoplasmic autoantibody-positive crescentic glomerulonephritis as a complication of treatment with propylthiouracil in children. J Pediatr 1994; 124: 986-988.
14. Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL, Hagen EC, Hoffman GS, Hunder GG, Kallenberg CG, et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 1994; 37: 187-192.
15. Gross WL, Trabandt A, Reinhold-Keller E. Diagnosis and evaluation of vasculitis. Rheumatology 2000; 39: 245-252.
16. Merkel PA. Drug-induced vasculitis. Rheum Dis Clin North Am 2001; 27: 849-862.
17. 14C] propylthiouracil in human polymorphonuclear leukocytes. Biochem Phamacol 1979; 28: 2289-2296.
18. Von Schmiedeberg S, Hanten U, Goebel C, Schuppe HC, Uetrecht J, Gleichmann E. T cells ignore the parent drug propylthiouracil but are sensitized to a reactive metabolite generated in vivo. Clin Immunol 1996; 80: 162-170.
19. Waldhauser L, Uetrecht J. Oxidation of propylthiouracil to reactive metabolites by activated neutrophils: implications for agranulocytosis. Drug Metab Dispos 1991; 19: 354-359.
20. Lee H, Hirouchi M, Hosokawa M, Sayo H, Kohno M, Kariya K. Inactivation of peroxidase of rat bone marrow by repeated administration of propylthiouracil is accompanied by a change in the heme structure. Biochem Phamacol 1988; 37: 2151-2153.
21. Harper L, Savage CO. Pathogenesis of ANCA-associated systemic vasculitis. J Pathol 2000; 190: 349-359.
22. Savage CO, Harper L, Holland M. New findings in pathogenesis of ANCA-associated vasculitis. Curr Opin Rheumatol 2002; 14: 15-22.
23. Tanemoto M, Miyakawa H, Hanai J, Yago M, Kitaoka M, Uchida S. Myeloperoxidase-antineutrophd cytoplasmic antibody-positive crescentic glomerulonephritis complicating the course of Graves' disease: report of three adult cases. Am J Kidney Dis 1995; 26: 774-780.
24. Yu F, Zhao MH, Zhang YK, Wang HY. Anti-endothelial cell antibodies (AECA) in patients with propylthiouracil (PTU) induced ANCA-positive vasculitis are associated with disease activity. Clin Exp Immunol 2005; 139: 569-574.
25. Harper L, Chin L, Daykin J, Allahabadia A, Heward J, Gough SC, Savage CO, Franklyn JA. Propylthiouracil and carbimazole associated-antineutrophil cytoplasmic antibodies (ANCA) in patients with Graves' disease. Clin Endocrinol 2004; 60: 671-675.
26. Cooper DS. Antithyroid drugs. N Engl J Med 2005; 352: 905-917.